Clinical Trial Update: A Clinical Trial With Apatinib for Subjects With Refractory Malignant Ascites [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Apatinib for subjects with refractory malignant ascites is described. The current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Ascites

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: The First Affiliated Hospital of Bengbu Medical University | Conditions: Malignant Ascites, Apatinib | Phase 2 | Status: UNKNOWN